GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Torrent Pharmaceuticals TORNTPHARM.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

4,780.00

+0.63%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹139.80bn

FY2017FY2026

Net income

₹21.63bn

FY2017FY2026

Free cash flow

₹19.55bn

FY2017FY2026

Shareholders' equity

₹83.89bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹139.80bn₹113.17bn₹105.62bn₹94.64bn₹84.19bn₹78.86bn₹77.80bn₹74.62bn₹58.25bn₹56.72bn
Research and development₹449.5m₹304.2m₹247.3m₹312.7m₹386.5m₹251.8m₹925.1m₹476.8m₹4.60bn₹4.32bn
Operating income₹34.62bn₹29.26bn₹25.72bn₹21.40bn₹17.69bn₹18.23bn₹15.19bn₹10.63bn₹9.41bn₹12.91bn
Net income₹21.63bn₹19.11bn₹16.56bn₹12.45bn₹7.77bn₹12.52bn₹10.25bn₹4.36bn₹6.78bn₹9.34bn
Diluted earnings per share63.9156.4749.0036.7922.9637.0530.2212.8419.9827.12

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹443.12bn₹149.90bn₹150.61bn₹150.12bn₹131.00bn₹140.75bn₹140.38bn₹141.21bn₹142.43bn₹101.25bn
Cash and short-term investments₹23.70bn₹6.91bn₹10.04bn₹8.35bn₹5.83bn₹7.38bn₹6.62bn₹11.67bn₹13.60bn₹16.94bn
Total liabilities₹267.27bn₹73.99bn₹82.04bn₹88.14bn₹71.47bn₹82.37bn₹92.15bn₹93.97bn₹96.21bn₹57.74bn
Debt—₹32.02bn₹40.22bn₹53.69bn₹40.70bn₹48.74bn₹58.40bn₹60.38bn₹64.62bn₹25.10bn
Shareholders' equity₹83.89bn₹75.91bn₹68.56bn₹61.98bn₹59.53bn₹58.37bn₹48.23bn₹47.24bn₹46.22bn₹43.50bn
Shares outstanding338m338m338m338m338m338m339m340m339m344m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹26.32bn₹25.85bn₹32.66bn₹23.68bn₹18.03bn₹20.11bn₹13.92bn₹17.98bn₹8.94bn₹10.13bn
Capital spending−₹6.77bn−₹6.11bn−₹4.33bn−₹5.74bn−₹2.03bn−₹3.35bn−₹4.07bn−₹6.63bn−₹7.91bn−₹4.87bn
Free cash flow₹19.55bn₹19.74bn₹28.33bn₹17.94bn₹16.00bn₹16.76bn₹9.85bn₹11.35bn₹1.03bn₹5.26bn
Dividends paid−₹12.89bn−₹10.83bn−₹10.15bn−₹8.63bn−₹6.77bn−₹3.38bn−₹7.18bn−₹3.10bn−₹2.65bn−₹2.04bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹49.21bn₹41.97bn₹32.51bn₹32.46bn₹31.28bn₹29.09bn₹27.62bn₹28.31bn
Operating income₹10.52bn₹8.48bn₹8.82bn₹8.79bn₹8.31bn₹7.63bn₹7.15bn₹7.41bn
Net income₹5.66bn₹3.89bn₹6.35bn₹5.91bn₹5.48bn₹4.98bn₹5.03bn₹4.53bn
Diluted earnings per share16.7211.4918.7617.4616.1914.7214.8813.40
Cash from operations———₹10.38bn—₹25.85bn—₹16.83bn
Capital spending———−₹1.96bn—−₹6.12bn—−₹2.26bn
Free cash flow———₹8.42bn—₹19.73bn—₹14.57bn
Total assets—₹443.12bn—₹155.15bn—₹149.90bn—₹150.88bn
Cash and short-term investments₹23.55bn₹23.70bn₹7.94bn₹10.33bn₹6.88bn₹6.91bn₹12.35bn₹12.35bn
Debt—₹148.72bn—₹28.22bn—₹32.02bn—₹31.26bn
Shareholders' equity₹175.85bn₹83.89bn₹84.49bn₹84.49bn₹75.91bn₹75.91bn₹75.04bn₹75.04bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.9%12.1%7.9%
Operating income17.4%13.7%3.2%
Net income20.2%11.6%2.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin25.3%24.5%23.8%23.2%
Net margin16.1%15.4%14.6%14.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings73.868.168.662.767.544.246.372.044.326.2
Price to sales11.411.510.88.36.27.06.14.25.24.3

Dividends and splits

Per share, in the currency the company pays

Paid for 31 years. Last went ex-dividend on 29 May 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year9.0035.0032.0030.0025.5020.0010.0018.00
  • 2-for-1 split · 8 Jul 2022
  • 2-for-1 split · 23 Jul 2013
  • 4-for-1 split · 20 Feb 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.